References
- Abrass, C. K., Appelbaum, J. S., Boyd, C. M., Braithwaite, R. S., Broudy, V. C., Covinsky, K., Crothers, K. A., Harrington, R., Drootin, M., Gebo, K., Goodkin, K., Havlik, R. J., Hazzard, W., High, K., Hsue, P., John, M. D., Justice, A., Karpiak, S., McCormick, W. C., … Valcour, V. (2012). Recommended treatment strategies for clinicians managing older patients with HIV (Report). The American Academy of HIV Medicine (AAHIVM).
- Akgun, K. M., Tate, J. P., Crothers, K., Crystal, S., Leaf, D. A., Womack, J., Brown, T. T., Justice, A. C., & Oursler, K. K. (2014). An adapted frailty-related phenotype and the VACS Index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000000341
- Becker, W. C., Gordon, K., Edelman, E. J., Kerns, R. D., Crystal, S., Dziura, J. D., Fiellin, L. E., Gordon, A. J., Goulet, J. L., Justice, A. C., & Fiellin, D. A. (2016). Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS and Behavior, 20(3), 679–686. https://doi.org/10.1007/s10461-015-1197-5
- Becker, W. C., Gordon, K., Edelman, E. J., Kerns, R. D., Crystal, S., Dziura, J. D., Fiellin, L. E., Gordon, A. J., Goulet, J. L., Justice, A. C., & Fiellin, D. A. (2017). Erratum to: Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS and Behavior, 21(4), 1228. https://doi.org/10.1007/s10461-017-1725-6
- Bortz, W. M., 2nd. (2002). A conceptual framework of frailty: A review. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57(5), M283–M288. https://doi.org/10.1093/gerona/57.5.M283
- Burkholder, G. A., Tamhane, A. R., Salinas, J. L., Mugavero, M. J., Raper, J. L., Westfall, A. O., Saag, M. S., & Willig, J. H. (2012). Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Journal of Biochemistry and Molecular Biology, 55(11), 1550–1557. https://doi.org/10.1093/cid/cis752
- Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013). Frailty in elderly people. Lancet, 381(9868), 752–762. https://doi.org/10.1016/s0140-6736(12)62167-9
- Deeks, S. G., & Phillips, A. N. (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ, 338(Jan 26 2), a3172. https://doi.org/10.1136/bmj.a3172
- Desquilbet, L., Margolick, J. B., Fried, L. P., Phair, J. P., Jamieson, B. D., Holloway, M., & Jacobson, L. P. (2009). Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 50(3), 299–306. https://doi.org/10.1097/QAI.0b013e3181945eb0
- Development, D. o. V. A. V. H. S. D. (February 2006 (revised)). National Drug File (NDF): Technical manual. http://www.va.gov/vdl/documents/Clinical/Pharm-National_Drug_File_(NDF)/psn_4_tm_r0206.pdf
- Edelman, E. J., Gordon, K. S., Glover, J., McNicholl, I. R., Fiellin, D. A., & Justice, A. C. (2013). The next therapeutic challenge in HIV: Polypharmacy. Drugs & Aging. https://doi.org/10.1007/s40266-013-0093-9
- Freiberg, M. S., Leaf, D. A., Goulet, J. L., Goetz, M. B., Oursler, K. K., Gibert, C. L., Rodriguez-Barradas, M. C., Butt, A. A., & Justice, A. C. (2009). The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication. Journal of General Internal Medicine, 24(3), 334–340. https://doi.org/10.1007/s11606-008-0891-7
- Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., & McBurnie, M. A. (2001). Frailty in older adults: Evidence for a phenotype. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 56(3), M146–M156. https://doi.org/10.1093/gerona/56.3.M146
- Fultz, S. L., Skanderson, M., Mole, L. A., Gandhi, N., Bryant, K., Crystal, S., & Justice, A. C. (2006). Development and verification of a “virtual” cohort using the National VA Health Information system. Medical Care, 44(8 Suppl 2), S25–S30. https://doi.org/10.1097/01.mlr.0000223670.00890.74
- Gandhi, N. R., Tate, J. P., Rodriguez-Barradas, M. C., Rimland, D., Goetz, M. B., Gibert, C., Brown, S. T., Mattocks, K., & Justice, A. C. (2013). Validation of an algorithm to identify antiretroviral-naive status at time of entry into a large, observational cohort of HIV-infected patients. Pharmacoepidemiology and Drug Safety, 22(9), 1019–1025. https://doi.org/10.1002/pds.3476
- Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Le Couteur, D. G. (2012). High-risk prescribing and incidence of frailty among older community-dwelling men. Clinical Pharmacology and Therapeutics, 91(3), 521–528. https://doi.org/10.1038/clpt.2011.258
- Goulet, J. L., Fultz, S. L., Rimland, D., Butt, A., Gibert, C., Rodriguez-Barradas, M., Bryant, K., & Justice, A. C. (2007). Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clinical Infectious Diseases, 45(12), 1593–1601. https://doi.org/10.1086/523577
- Joshi, D., O’Grady, J., Dieterich, D., Gazzard, B., & Agarwal, K. (2011). Increasing burden of liver disease in patients with HIV infection. Lancet, 377(9772), 1198–1209. https://doi.org/10.1016/s0140-6736(10)62001-6
- Justice, A. C. (2010). HIV and aging: Time for a new paradigm. Current HIV/AIDS Reports, 7(2), 69–76. https://doi.org/10.1007/s11904-010-0041-9
- Justice, A. C., Gordon, K. S., Skanderson, M., Edelman, E. J., Akgün, K. M., Gibert, C. L., Cynthia, L., Lo Re, V. I., Rimland, D., Womack, J. A., Wyatt, C. M., Tate, J. P., & Team, V. P. (2018). Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals. AIDS (London, England), 32(6), 739–749. https://doi.org/10.1097/QAD.0000000000001756
- Jyrkka, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011). Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiology and Drug Safety, 20(5), 514–522. https://doi.org/10.1002/pds.2116
- Kim, T. W., Walley, A. Y., Ventura, A. S., Patts, G. J., Heeren, T. C., Lerner, G. B., Mauricio, N., & Saitz, R. (2018). Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care, 30(2), 150–159. https://doi.org/10.1080/09540121.2017.1384532
- Lucas, G. M., Mehta, S. H., Atta, M. G., Kirk, G. D., Galai, N., Vlahov, D., & Moore, R. D. (2007). End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS (London, England), 21(18), 2435–2443. https://doi.org/10.1097/QAD.0b013e32827038ad
- Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57–65. https://doi.org/10.1517/14740338.2013.827660
- (OARAC), D. P. o. A. G. f. A. a. A. A. W. G. o. t. O. o. A. R. A. C. (2018). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. https://aidsinfo.nih.gov/guidelines
- Onen, N. F., Agbebi, A., Shacham, E., Stamm, K. E., Onen, A. R., & Overton, E. T. (2009). Frailty among HIV-infected persons in an urban outpatient care setting. The Journal of Infection, 59(5), 346–352. https://doi.org/10.1016/j.jinf.2009.08.008
- Rockwood, K. (2005). Frailty and its definition: A worthy challenge. Journal of the American Geriatrics Society, 53(6), 1069–1070. https://doi.org/10.1111/j.1532-5415.2005.53312.x
- Rockwood, K., & Mitnitski, A. (2011). Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clinics in Geriatric Medicine, 27(1), 17–26. https://doi.org/10.1016/j.cger.2010.08.008
- Saunders, K. W., Dunn, K. M., Merrill, J. O., Sullivan, M., Weisner, C., Braden, J. B., Psaty, B. M., & Von Korff, M. (2010). Relationship of opioid use and dosage levels to fractures in older chronic pain patients. Journal of General Internal Medicine, 25(4), 310–315. https://doi.org/10.1007/s11606-009-1218-z
- Ssonko, M., Stanaway, F., Mayanja, H. K., Namuleme, T., Cumming, R., Kyalimpa, J. L., Karamagi, Y., Mukasa, B., & Naganathan, V. (2018). Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda. BMC Geriatrics, 18(1), 125. https://doi.org/10.1186/s12877-018-0817-0
- Walston, J., Hadley, E. C., Ferrucci, L., Guralnik, J. M., Newman, A. B., Studenski, S. A., Ershler, W. B., Harris, T., & Fried, L. P. (2006). Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on frailty in older adults. Journal of the American Geriatrics Society, 54(6), 991–1001. https://doi.org/10.1111/j.1532-5415.2006.00745.x
- Ware, D., Palella, F. J., Jr., Chew, K. W., Friedman, M. R., D’Souza, G., Ho, K., & Plankey, M. (2018). Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016. PLoS One, 13(9), e0203890. https://doi.org/10.1371/journal.pone.0203890